Items where authors include "Surmont, V."

Article

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Ejedepang, D. et al. (19 more authors) (2021) Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung Cancer, 161. pp. 76-85. ISSN 0169-5002

Faivre-Finn, C., Snee, M., Ashcroft, L. et al. (17 more authors) (2017) Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet Oncology, 18 (8). pp. 1116-1125. ISSN 1470-2045

O'Brien, M.E.R., Gaafar, R., Hasan, B. et al. (12 more authors) (2015) Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064). European Journal of Cancer, 51 (12). pp. 1511-1528. ISSN 0959-8049